CALLABLE MULTI DEFENDER VONTI - BAYER/ROCHE GS Share Price

Certificat

RMACOV

CH1255347424

Market Closed - Swiss Exchange 08:50:00 03/10/2023 pm IST
95.5 EUR -1.44% Intraday chart for CALLABLE MULTI DEFENDER VONTI - BAYER/ROCHE GS
1 month-3.92%
3 months-5.26%

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
RMACOV
ISINCH1255347424
Date issued 03/05/2023
Strike 281.1 CHF
Maturity 05/05/2025 (349 Days)
Parity 0.28 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 101.8
Lowest since issue 95.5

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
234.4 CHF
Average target price
279.4 CHF
Spread / Average Target
+19.19%
Consensus
  1. Stock Market
  2. Certificates
  3. RMACOV Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW